Abbott · 6 hours ago
Specimen Processor II, DOT
Abbott is a global healthcare leader that helps people live more fully at all stages of life. The Specimen Processor II, DOT role involves receiving and processing specimens in accordance with regulatory guidelines, ensuring proper documentation and handling of samples.
BiotechnologyEmergency MedicineGeneticsHealth CareHealth DiagnosticsManufacturingMedicalMedical DeviceNutritionPharmaceutical
Responsibilities
Process samples that fall under SAMHSA/DOT regulations and are subject to interviews during NLCP inspection and/or audits
Receive and open specimens delivered to the laboratory for analysis
Review and document acceptability of specimen and chain of custody forms
Assign laboratory accessioning numbers and aliquot specimens
Destroy specimens as needed
Clean and maintain work area daily
Inspect all trash bags once aliquoting process is completed to ensure sample and document removal
Process Triage request
Assist Sample Handling area
Prepare samples for shipment
Adhere to all security procedures for ensuring confidentiality of donor information
Must comply with company policy
Qualification
Required
High School education
Preferred
Basic ability to use a computer
Basic ability to understand laboratory technique and procedures
Advanced ability to understand certification requirements for SAMSHA, CAP-PUDT, and other relevant regulatory bodies
Basic ability to understand the function of a Laboratory Information System (LIS) and other laboratory computer systems
Benefits
Free medical coverage in our Health Investment Plan (HIP) PPO medical plan in the next calendar year
An excellent retirement savings plan with high employer contribution
Tuition reimbursement
The Freedom 2 Save student debt program
FreeU education benefit - an affordable and convenient path to getting a bachelor’s degree
Company
Abbott
Abbott is a healthcare company that produces diagnostic kits, medical devices, nutritional products, and branded generic medicines.
Funding
Current Stage
Public CompanyTotal Funding
$6.79M2011-03-15Post Ipo Debt· $0.1M
2009-03-16Post Ipo Debt· $6.69M
1980-12-12IPO
Recent News
2025-12-18
Company data provided by crunchbase